跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 31,821 条关于
“Flexi-Port™ SLF-TANL™”
全部
31,821
临床试验
28,748
药物
589
机构
90
资讯
2,394
去年
Portal Access Secures $7M Series A to Advance Next-Generation Chemotherapy Port Through FDA Approval
去年
Medtronic's Affera System with Sphere-9 Catheter Receives FDA Approval for Atrial Fibrillation Treatment
去年
Medtronic's Affera System Receives FDA Approval for Atrial Fibrillation and Flutter Treatment
3年前
Darolutamide Approved in China for Metastatic Hormone-Sensitive Prostate Cancer
2年前
Abbott's TactiFlex Ablation Catheter Receives FDA Clearance for Atrial Fibrillation Treatment
2年前
Pluvicto Demonstrates Significant Radiographic Progression-Free Survival Benefit in PSMA-Positive mCRPC
去年
FDA Approves Iterum's Oral Sulopenem (ORLYNVAH™) for Uncomplicated Urinary Tract Infections
去年
HyBryte Shows Sustained Improvement in CTCL Lesions Post-Treatment
去年
FDA Approves ROXYBOND™ 10 mg for Pain Management with Abuse-Deterrent Technology
去年
FDA Approves Phraxis' EndoForce™ Connector, Advancing Hemodialysis Access Technology
第 1 页,共 240 页
上一页
下一页